Jeil Bio Rises 5.56% Amid Rising Interest in Anthelmintic Drugs (Fenbendazole, etc.) Theme

On the 14th, the deworming drug theme (including Fenbendazole) showed strength, rising 4.00% compared to the previous day, while Jeil Bio, a related stock drawing attention, surged 5.56% compared to the previous day. Jeil Bio is known as a manufacturer specializing in veterinary pharmaceuticals.

[Graph] Major stock price changes in the deworming drug theme (including Fenbendazole)



According to the analysis by Thinkpool Robo Algorithm RASSI, Jeil Bio’s quant financial score is 24.96 points, ranking 3rd within the deworming drug theme due to higher stability and profitability scores compared to the average of other related stocks. This indicates that, from a financial perspective, Jeil Bio’s ability to respond to internal and external economic environment changes and its efficient profit-generating capacity are better than those of other stocks in the theme.

[Table] Top stocks by financial score within the theme


※ The quant financial score is the result of the robo algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.